Biodesix, Inc.BDSXNASDAQ

|||

Switch Symbol:

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 71% recommend buying.

Consensus Rating

Buy

7 analysts·Limited coverage

71%

Rating Distribution

Strong Buy

00%

Buy

571%

Hold

229%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 81% higher.

Bear Case

$20.00

+81%

Consensus

$20.00

+81%

Bull Case

$20.00

+81%

Price Range7 analysts

Low

Consensus

High

$20.00

Current Target

Current Price

$11.03

Upside to Target

$8.97

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-2.43(3 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+22.08%

EPS—

FY2028

Rev+23.73%

EPS—

FY2029

Rev+14.01%

EPS—

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+8.8%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Sep 19, 2025Canaccord Genuity

Biodesix price target lowered to $20 from $30 at Canaccord

Target:$20.00

+199.0%from $6.69

Sep 16, 2024Scotiabank

Biodesix initiated with an Outperform at Scotiabank

Target:$3.00

+64.8%from $1.82

Jul 26, 2024Craig-Hallum

Craig-Hallum Starts Biodesix (BDSX) at Buy

Target:$3.00

+78.6%from $1.68

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance